Results 71 to 80 of about 18,005 (212)

Coverage of education and training of traumatic brain injury-induced growth hormone deficiency in US residency and fellowship programs: a cross-sectional study

BMC Medical Education
Background Hypopituitarism, including growth hormone deficiency (GHD), is a common sequela of traumatic brain injury (TBI). This study explored the coverage of education and training of TBI-induced hypopituitarism in general and GHD in particular, in ...
Javier Cárdenas, Nicky Kelepouris, Radhika Adiga, Kevin C. J. Yuen   +3 more
doaj   +1 more source

The Spectrum of Congenital Hypogonadotropic Hypogonadism: A 30‐Year Experience at a Tertiary Paediatric Centre

Clinical Endocrinology, Volume 105, Issue 4, Page 464-473, October 2026.
ABSTRACT Congenital hypogonadotropic hypogonadism (CHH) is a rare group of disorders of gonadotropin deficiency, either isolated or as a part of multiple pituitary hormone deficiencies (MPHD). We aimed to describe the spectrum of presentation, diagnosis, and management practices of CHH spanning 30 years at an Australian tertiary paediatric centre. This
Minha Kook, Richard G. McGee, Geoffrey Ambler, Yoon Hi Cho   +3 more
wiley   +1 more source

Hypopituitarism, A Sequel to TBI

, 2014
Investigators at Cincinnati Children's Hospital, OH, studied the prevalence of hypopituitarism in children with inflicted traumatic brain ...
John J Millichap, J Gordon Millichap, Millichap, J. Gordon, Millichap, John J.   +3 more
core   +1 more source

IMPROVE 2025: The 3rd International Meeting on Pathway‐Related Obesity: Vision & Evidence

Clinical Obesity, Volume 16, Issue 5, October 2026.
ABSTRACT An international cohort of 161 clinicians and researchers from 19 countries attended the 3rd International Meeting on Pathway‐Related Obesity: Vision & Evidence (IMPROVE) in Prague, Czech Republic, on 2–4 July 2025. The aims of the meeting were to advance understanding of hyperphagia and obesity caused by defects in the melanocortin‐4 receptor
Jesús Argente, Erica L. T. van den Akker, Metin Cetiner, Karine Clément, Elizabeth Forsythe, Alastair Garfield, Peter Kühnen, Gabriel Ángel Martos‐Moreno, David Meeker, Hermann L. Müller, Hanneke M. van Santen, Julia von Schnurbein, Bérénice Segrestin, Tomohiro Tanaka, Manuel Tena‐Sempere, Martin Wabitsch, Stefanie Zorn, I. Sadaf Farooqi   +17 more
wiley   +1 more source

Immune function in hypopituitarism: Time to reconsider?

, 2009
Hypopituitarism is not currently considered as a potential cause of immune disruption in humans. Accumulating data from in vitro and animal models support a role for the pituitary gland in immune regulation.
Helbert, Matthew, Davis, Julian, Mukherjee, Annice, Shalet, Stephen, Davis, J R E, Shalet, Stephen M, Helbert, M, Stephen Shalet, Julian Davis, Matthew Helbert, Annice Mukherjee   +10 more
core   +1 more source

The changing clinical spectrum of hypopituitarism [PDF]

, 2019
Hypopituitarism is an uncommon condition with a prevalence of nearly 50 per 100 000. Historically, Sheehan syndrome and pituitary apoplexy were important causes of hypopituitarism at the beginning of the 20ts century.
VALDES SOCIN, Hernan Gonzalo
core   +1 more source

Unveiling the psychiatric dimensions of hypopituitarism: investigating associations, challenges, and treatment strategies

Journal of the Pakistan Medical Association
Dear Editor, Hypopituitarism is a disorder characterized by insufficient hormone production from the pituitary gland,1,2 manifesting as either pan or partial dysfunction.2 Hypopituitarism is considered a rare disorder by National Institute of Health ...
Ayesha Imran Butt, Muhammad Juniad Azhar
doaj   +1 more source

Genetic landscape of a neonatal hypogonadotropic hypogonadism series: Novel variants and phenotypic spectrum

Journal of Neuroendocrinology, Volume 38, Issue 10, October 2026.
Abstract To describe clinical presentation and genetic findings in a cohort of infants with congenital hypogonadotropic hypogonadism (CHH) diagnosed before 2 years of age. From a large cohort of patients who underwent next‐generation sequencing (NGS) for CHH between 2019 and 2025, we identified all patients tested at ≤2 years of age.
Karine Aouchiche, Laure Van Wormhoudt, Kevin Perge, Joanne Dornberger, Cindy Colson, Marine Delagrange, Clara Leroy, Jennifer Ledmazel, Vanessa Menut, Jessica Benarrous Jaillet, Djamel Bendifallah, Mohamad Hage Chehade, Christelle Dib, Anne Barlier, Thierry Brue, Rachel Reynaud, Alexandru Saveanu   +16 more
wiley   +1 more source

Hypopituitarism Induced by Continuous Infusion of PGI2 Analogues: A Case Series and the Role of ACTH Screening and Hydrocortisone Treatment

Pulmonary Circulation
Hypopituitarism has been reported in patients receiving continuous infusions of prostaglandin I2 (PGI2) analogues for pulmonary hypertension (PH). However, these patients' clinical characteristics, treatment, and prognoses remain unclear.
Taijyu Satoh, Yuichi Tamura, Noriaki Takama, Hiromi Matsubara, Nobuhiro Tanabe, Takumi Inami, Takahiro Hiraide, Kohtaro Abe, Yoshihiro Dohi, Yoshito Ogihara, Takeshi Ogo, Shiro Adachi, Kazuhiko Nakazato, Ichizo Tsujino, Hideki Ota, Kohei Komaru, Haruka Sato, Yuta Tezuka, Yoshikiyo Ono, Rika Suda, Kazuya Hosokawa, Sarasa Isobe, Takatoyo Kiko, Yuki Koga, Junichi Nakamura, Koichiro Sugimura, Masaru Hatano, Yoshihiro Fukumoto, Satoshi Yasuda   +28 more
doaj   +1 more source

Clinical Profile of Patients with Hypopituitarism in a Tertiary Care Centre in Central India

Indian Journal of Endocrinology and Metabolism
Introduction: Hypopituitarism is a serious endocrine illness with life-threatening implications. There is a lack of reliable Indian epidemiological data, with very few studies on hypopituitarism across the country.
Vinay R. Pandit, Kritika Pant, Amritava Ghosh, Pankaj K. Kannauje, Jhasaketan Meher   +4 more
doaj   +1 more source